RLYB
RLYB
NASDAQ · Biotechnology

Rallybio Corp

$16.00
-0.06 (-0.37%)
As of Jun 30, 10:25 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -13.6% upside
Low Target $9.36
Average Target $13.83
High Target $17.78
Current Price $16.00
Current
$16.00
Target
$13.83
$9.36 $13.83 avg $17.78
Scenario Analysis
Bear Case
$9.36
-41.5%
Low target
Base Case
$13.83
-13.6%
Avg target
Bull Case
$17.78
+11.1%
High target
Risk/Reward
0.3x
Unfavorable
Price in Context
52-Week High
$17.57
-9.0% from high
52-Week Low
$2.55
+527.5% from low
Target vs 52W High
$13.83
-21.3% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%